This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of …. Domestic innovation is measured as citation-weighted domestic patents filed at the European Patent Office (EPO): to account for … to patent at the EPO. Results show that, in the short-run, IPR stimulate innovation. The effect for developing countries …

Public-private partnerships offer a promising alternative paradigm for pharmaceutical innovation in complex disease … essential to accelerate pharmaceutical innovation. Patents threaten the potential of partnership strategies, however, by making … innovation is fundamentally flawed for two reasons. First, it ignores the competitive market pressures that both shape what is …

different configurations of the patent system upon innovation and competition. The model is able to replicate the main stylized … adverse effects in terms of innovation outcomes, as well as of market competition and consumer welfare. Such general …

‘performed' R&D and ‘extra-mural' R&D, and focuses on R&D productivity and patent quality as key indicators of innovation. The …

the functioning of the patent system, innovation researchers have been surprisingly silent on the topic. This paper …